Bijuva Cost Without Insurance: What You’ll Actually Pay in 2026 (and How to Pay Less)

Last verified: June 2026 · Editorial research by The HRT Index — educational only, not medical advice, and not reviewed by a clinician. Affiliate disclosure: The HRT Index may earn a commission if you start care through some provider links on this page (Midi, Sesame), at no extra cost to you. That never changes the prices we report or who we recommend.

Bijuva cost without insurance runs about $269–$353 for 30 capsules in 2026, based on current retail and cash-price references. Pharmacy discount cards can bring that down to roughly $50–$241. There’s no generic Bijuva, and the manufacturer copay card doesn’t cover cash-paying patients — though separate FDA-approved estradiol and progesterone can cost far less.

Here’s the part that trips almost everyone up. The manufacturer “savings card” you’ve probably already Googled won’t help you if you’re paying cash — its official terms require commercial insurance and specifically exclude cash-paying patients. Most coupon pages won’t tell you that. We will, and we’ll show you the routes that actually work for you instead — including the one that runs about $25 to $70 a month.

We’re The HRT Index, an independent menopause-HRT decision resource for women. We read every price ourselves, date it, and trace it to the source. Below is every real way to pay for Bijuva, who each one fits, and exactly what to ask before you hand over a card.

First, one honest thing about “the right provider”

The right online HRT provider isn’t the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can’t resolve those for you, use The HRT Index’s Find My HRT Path toolto match your situation to the right provider — and to flag when online care isn’t the right starting point — before your first consult. It takes about 90 seconds, asks only what’s needed, and your answers are handled under our consumer-health-data and privacy policy.

The HRT Indexis the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

Bijuva cost without insurance — every route, verified (June 2026)

This is the table we wish existed when we started digging. To build it, you’d otherwise have to open GoodRx, SingleCare, and Drugs.com, read the manufacturer’s official copay-card document, find Mayne Pharma’s separate Medicare program page, and then price two different generic medications on their own. We did all of that. Prices are current as of June 2026and will move — treat each as a dated reference to re-check at checkout.

The big picture:at full retail you’re looking at roughly $3,228 to $4,240 a year. The separate-generics route can land closer to $300 to $840 a yearfor the same two hormones. That gap — often $2,000+ a year — is the whole reason this page exists.

Which route fits your situation?

Not sure whether Bijuva is even the right thing for you to pay for? See your personal lowest-cost route with The HRT Index’s Find My HRT Path tool — about 90 seconds, no sign-up.

How much does Bijuva cost without insurance?

Bijuva costs about $269 to $353 for 30 capsules without insurance in 2026, based on current published cash prices. Pharmacy discount cards can lower that to roughly $50 to $241, but those prices change often and must be confirmed at the pharmacy counter. There is no single fixed “Bijuva price” — it depends on the pharmacy, the strength, and the discount you use.

Let’s break down why the number moves so much.

It changes by source

On the day we checked, SingleCare listed an average retail price near $353, GoodRx near $309 ($308.72), and Drugs.com from about $269. Same drug, same month — a roughly $84 spread just between price databases. That’s normal for brand-name medications, because each platform negotiates its own pharmacy rates.

It barely changes by strength

Bijuva comes in two strengths — 0.5 mg estradiol / 100 mg progesterone and 1 mg estradiol / 100 mg progesterone — and they cost about the same. So you can’t save money by asking for a different strength. (Estradiol is a form of estrogen; progesterone is the hormone that protects the lining of the uterus when you take estrogen. Bijuva combines both in one capsule.)

It changes a lot by discount

The difference between paying full retail (~$353) and showing a discount card (~$50–$241) is the single biggest lever you control without involving your doctor.

The practical move before you pay: check your local discount-card price first, confirm whether any manufacturer program applies to yourinsurance type (most don’t, as you’ll see next), and ask your doctor whether separate FDA-approved hormones make sense if Bijuva is out of reach. Do those three things and you’ll almost never overpay.

Can you use the Bijuva savings card without insurance?

No.The Bijuva manufacturer copay card is not a cash-pay coupon. Its official terms require you to have a commercial insurance plan that covers Bijuva, and the card specifically states it is not valid for cash-paying patients or for any government plan, including Medicare, Medicaid, and TRICARE. If you’re uninsured and paying out of pocket, this card cannot lower your price.

This is the most important thing on the page, so let’s be precise. We pulled the actual card terms from Mayne Pharma’s official document. Here’s what it says, in plain words:

• You must be commercially insured— and your plan has to cover a valid Bijuva prescription at the pharmacy.
• It is not valid for a cash-paying patient. Those words are right in the terms.
• It is not valid for government coverage— Medicare, Medicaid, Medicare Advantage, Part D, Medigap, TRICARE, VA, and more.
• It is not valid for certain HMO plans that fully reimburse the drug.
• You can’t get reimbursed through an FSA or HSA for the card’s value.
• It expires December 31, 2026 (verify before you count on it). The program is run by InfinityRx; their help line is 1‑888‑927‑3499.

So why are you seeing “Bijuva as low as $XX” everywhere?

Because coupon pages blur five very different things into one word — “savings”:

1. A manufacturer copay card(commercial insurance only — the one above).
2. A pharmacy discount card like GoodRx or SingleCare (works for cash-pay).
3. A home-delivery cash price.
4. A Medicare-specific program (different rules entirely).
5. Your insurance’s own coverage (a formulary).

Only one of those — the pharmacy discount card — reliably helps a cash-paying woman. When a page says “as low as” but the official card excludes your situation, trust the official terms and check the real checkout price before you transfer your prescription.

Here’s the honest admission, and the hope right behind it. If you’re truly paying cash, the manufacturer card was never your lever — and that’s actually fine. The levers that do work for you (a pharmacy discount card, or the separate-generics conversation with your doctor) are often cheaperthan that card would have made it anyway. You’re not stuck at $353. You just needed someone to point you at the right door.

Is there a generic for Bijuva?

There is no FDA-approved generic version of Bijuva. The combination capsule is brand-only — Drugs.com’s generic-availability page confirms the FDA has not approved a generic, and lists patents protecting the product through November 21, 2032. But the two hormones inside it, estradiol and progesterone, both exist as inexpensive FDA-approved generics on their own, so “no generic Bijuva” does not mean “no cheaper option.”

This is where a lot of pages get it flat wrong. We’ve seen sites claim a generic Bijuva exists. As of June 2026, it doesn’t — and with patents running to late 2032, an FDA-approved generic of the capsule isn’t expected anytime soon. Don’t go to a pharmacy expecting a $15 generic of the capsule. And be careful online: Drugs.com warns that fraudulent pharmacies may try to sell an illegal “generic Bijuva” that could be counterfeit and unsafe.

But here’s the hopeful part. Bijuva is two well-established hormones, combined into one pill for convenience. Both of those hormones have had cheap generics for years — sold separately, not as the same product. Here’s how your options actually stack up:

The takeaway: there’s no shortcut generic of the Bijuva capsule itself, but there is a legitimate, doctor-directed path using the same two hormones as separate generics — and it can cost less than half. The next section shows the numbers.

What’s the cheapest way to get Bijuva without insurance?

For cash-paying women, the two routes that genuinely lower Bijuva’s cost are a pharmacy discount card (about $50 to $241 per month) and, with a doctor’s agreement, switching to separate generic estradiol and progesterone (about $25 to $70 per month). The manufacturer copay card does not apply to cash-pay patients, so it is not part of this list.

Route 1: A pharmacy discount card

These are the GoodRx / SingleCare-style cards, and unlike the manufacturer card, they’re built for people without coverage.

• On our June 2026 check, GoodRx listed Bijuva as low as about $50, and SingleCare listed a coupon price near $241. That’s a five-fold spread between two cards on the same drug — which is exactly why you check more than one.
• The catch: discount-card prices bounce around week to week and pharmacy to pharmacy. The price you see online isn’t locked until the pharmacist runs it.
• You can’tstack a discount card on top of insurance. It’s one or the other per fill.

Route 2: The separate-generics conversation (often the cheapest)

This is usually the lowest-cost legitimate path, and it’s a doctor decision — not a pharmacy-counter swap. The honest framing: ask your prescriber whether separate FDA-approved estradiol and progesterone can meet the same treatment goal. They are not Bijuva, not the same FDA-approved combination product, and not an automatic substitute — but for many women, they’re a reasonable, far cheaper option.

If you need a prescription and you’re cash-paying, a cash-pay telehealth visit is often the fastest path to getting the right hormones evaluated and prescribed.

For cash-pay women who need a prescription

Sesame is a cash-pay telehealth marketplace where clinicians list their own prices — no insurance billing, no surprise fees. It connects you with a licensed clinician who can evaluate you and, if appropriate, prescribe FDA-approved estradiol or other hormones and send them to your pharmacy, where you still use your discount card.

Need a cash-pay prescription visit?Compare clinician pricing and availability on Sesame — medication costs are separate.

→ · Prescriptions written only if clinically appropriate. Medication costs are separate.

If you have PPO insurance or want ongoing menopause care

Midi is a telehealth practice focused on midlife women’s health, in all 50 states and in-network with most PPO plans. Most insured patients average around $50 out of pocket per visit (deductibles and copays still apply); self-pay is $250 for the first visit and $150 for follow-ups, not counting labs or medications. Its clinicians prescribe FDA-approved estradiol (including pills, patches, and gels) and oral micronized progesterone. One limit to know plainly: Midi isn’t covered by Medicare and can’t treat Medicaid patients.

Have PPO insurance or want a menopause-focused clinician? Check whether Midi is in-network in your state before you book.

→

A clear word on compounded hormones

You may see “bioidentical” compounded hormones marketed as a cheaper alternative. Compounded drugs are mixed by a pharmacy for an individual and are not FDA-approved— the FDA does not verify their safety, quality, or strength before they’re dispensed. Major medical groups recommend FDA-approved products for most people. We don’t recommend compounded as a way to save on Bijuva. The FDA-approved options on this page are regulated — and often far cheaper than brand Bijuva, depending on the route and pharmacy. If you have a specific medical reason to consider compounded, that’s a conversation for your clinician. (We cover it in our guide to FDA-approved vs. compounded HRT.)

What women say about Bijuva

We include this for one reason: to show you that you’re not the only one weighing whether this is worth it — and that real experiences run both ways.

On the positive side, one of WebMD’s most-helpful reviews described hot flashes as “GONE”within about two days of starting. That’s one patient’s review, not a typical-results claim — other reviewers report side effects or no benefit, describing low mood, weight gain and sugar cravings, headaches or migraines, or simply no relief from their hot flashes. And across menopause forums, cost is one of the most common reasons women say they stop or never start — which is the entire problem this page is built to solve.

Patient reviews are experience, not evidence. We don’t use them to rank anything or to prove a medication works. A medication’s real safety and effectiveness come from the FDA label and your clinician — not from star ratings, and not from us.

How we verified this — The HRT Index Verification Standard

Every claim on this page was checked against a source and dated. That’s our HRT Index Verification Standard— the documented process by which we read every published price, separate FDA-approved from compounded options, confirm state and insurance details, and re-check on a fixed schedule (top providers monthly, the full roster quarterly). We evaluate every option through five pillars, always in this order: clinical legitimacy, care quality, medication fit, price transparency, and access. We don’t assign numeric scores.

What we actually verified (June 2026)

• Cash prices from GoodRx (avg ~$309; low ~$50), SingleCare (avg ~$353; coupon ~$241), and Drugs.com (from ~$269).
• The manufacturer copay card terms— commercial insurance required; cash-paying patients and government plans excluded; expires Dec 31, 2026 — read directly from Mayne Pharma’s official card document.
• The Medicare Part D coupon program— eligibility, the calendar-year opt-out, and the opt-out letter — from Mayne’s official program page.
• Generic pricing for oral estradiol (as low as ~$9/30 days) and micronized progesterone (as low as ~$14/30 days), from GoodRx.
• Bijuva’s current FDA label (revised 2/2026): indication, dosing, strengths, contraindications, warnings, and the February 2026 removal of the boxed warning and probable-dementia warning.
• No FDA-approved genericand patents through November 21, 2032, from Drugs.com’s generic-availability page.
• Provider factsfor Midi (in-network most PPOs, 50 states, $250/$150 self-pay, ~$50 avg insured copay, no Medicaid/Medicare) and Sesame (cash-pay menopause care, no insurance billing), from each provider’s own pages.
• Patient ratings from WebMD (4.5/5, 105 reviews) and Drugs.com (6.0/10, 54 reviews). Accessed June 2026.

What still needs your check

Your exact local pharmacy price, your dose and quantity, your discount-card eligibility, your state’s rules, your insurance formulary, your Medicare specifics, and whether a given provider can evaluate and prescribe for you. We can give you the map. The last mile is yours.

Who made this: The HRT Index Editorial Team. Medical review status: This is editorial research, not medical advice, and it is not reviewed by a clinician. For decisions about your body, talk to one.

Bijuva cost FAQ

How much does Bijuva cost without insurance?

Bijuva costs about $269 to $353 for 30 capsules without insurance in 2026 at standard cash prices. Pharmacy discount cards can lower that to roughly $50 to $241, and the separate-generics route costs about $25 to $70 a month. Confirm your dose, ZIP, pharmacy, and any discount at checkout before paying.

Is there a generic for Bijuva?

No. As of 2026, there is no FDA-approved generic version of the Bijuva capsule — it’s brand-only, with patents through November 21, 2032. However, the two hormones inside it, estradiol and progesterone, are each available as inexpensive FDA-approved generics, which a clinician may consider as separate prescriptions when appropriate. Be wary of any site claiming to sell a “generic Bijuva,” as it may be counterfeit.

Can I use the Bijuva savings card if I don’t have insurance?

No. The official Bijuva copay card requires commercial insurance that covers the prescription, and it explicitly excludes cash-paying patients as well as Medicare, Medicaid, TRICARE, and other government plans. Cash-pay women should use a pharmacy discount card or ask about generic options instead.

Does Medicare cover Bijuva?

It depends on your plan — some Part D and Medicare Advantage drug plans cover Bijuva, many require prior authorization, and some don’t cover it. The manufacturer copay card can’t be used with Medicare, but Mayne offers a separate Medicare Part D coupon program. Using it means opting out of your Part D benefit for Bijuva for the rest of the calendar year, so weigh it carefully — the generic route is often cheapest for Medicare members.

What’s the cheapest way to get Bijuva without insurance?

For most uninsured women, the cheapest legitimate path is asking your prescriber whether separate FDA-approved estradiol and progesterone — the two active hormones in Bijuva — can meet the same treatment goal when the clinician decides separate prescriptions fit. That runs about $25 to $70 a month combined. Trade-offs: two pills instead of one, not the identical FDA-approved combination, and the generic progesterone is usually made in peanut oil.

Is Bijuva bioidentical?

Yes. Bijuva uses estradiol and progesterone that are bioidentical, meaning they have the same molecular structure as the hormones your body makes, and it is the only FDA-approved bioidentical estradiol-plus-progesterone combination capsule. “Bioidentical” describes the molecule — it does not, by itself, mean a product is safer or better for any specific person.

Did the FDA remove Bijuva’s black box warning?

Yes. On February 12, 2026, the FDA removed Bijuva’s boxed warning covering cardiovascular disease, breast cancer, probable dementia, and endometrial cancer, and removed its probable-dementia warning entirely, as part of a labeling update across six menopausal hormone therapies. Important contraindications and warnings still remain in the label, so it is not risk-free.

Can an online provider prescribe Bijuva?

Possibly. A licensed online clinician can evaluate your menopause symptoms and may prescribe an appropriate FDA-approved hormone therapy if it’s clinically suitable and legal in your state. No provider can promise to prescribe Bijuva specifically before evaluating you, so confirm during your visit.

Your next step

You came for a price, and now you have it — about $269 to $353 a month at retail, with real paths down to $50 or even $25 a month, and a clear answer on why the manufacturer card isn’t one of them for cash-pay. The only thing left is matching the right route to your situation: your insurance, your state, your history.

That’s the one thing a price page can’t do for you. Our tool can.